creatine has been researched along with Coronary Disease in 46 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperthyroid rat heart was studied with the purpose of identifying the mechanism for the significant decrease in total creatine (free creatine plus phosphocreatine) observed in this pathology and its consequences on heart function." | 7.67 | Hormone regulation of cardiac energy metabolism. I. Creatine transport across cell membranes of euthyroid and hyperthyroid rat heart. ( Adoyaan, AJ; Chernousova, GB; Kallikorm, AP; Lyulina, NV; Popovich, MI; Saks, VA; Seppet, EK; Severin, VV; Sharov, VG, 1985) |
| "We measured creatine kinase activity, isozyme composition, and total creatine content in biopsy samples of left ventricular myocardium from 34 adults in four groups: subjects with normal left ventricles, patients with left ventricular hypertrophy due to aortic stenosis, patients with coronary artery disease without left ventricular hypertrophy, and patients with coronary artery disease and left ventricular hypertrophy due to aortic stenosis." | 3.67 | The creatine kinase system in normal and diseased human myocardium. ( Allen, PD; Fifer, MA; Grossman, W; Ingwall, JS; Kramer, MF; Lorell, BH; Shemin, R, 1985) |
| "Hyperthyroid rat heart was studied with the purpose of identifying the mechanism for the significant decrease in total creatine (free creatine plus phosphocreatine) observed in this pathology and its consequences on heart function." | 3.67 | Hormone regulation of cardiac energy metabolism. I. Creatine transport across cell membranes of euthyroid and hyperthyroid rat heart. ( Adoyaan, AJ; Chernousova, GB; Kallikorm, AP; Lyulina, NV; Popovich, MI; Saks, VA; Seppet, EK; Severin, VV; Sharov, VG, 1985) |
| "The high prevalence of small LDL in diabetic nephropathy was also observed even when hypertriglyceridemic or hypertensive subjects were excluded from each group." | 1.29 | High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy. ( Adachi, M; Ebara, T; Hirano, T; Kurokawa, M; Nagano, S; Naito, H; Yoshino, G, 1996) |
| "When verapamil was present before ischemia, pressure development during early ischemia was reduced to about 50% of control." | 1.27 | Verapamil protection of ischemic isolated rabbit heart: dependence on pretreatment. ( Bersohn, MM; Shine, KI, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (78.26) | 18.7374 |
| 1990's | 5 (10.87) | 18.2507 |
| 2000's | 4 (8.70) | 29.6817 |
| 2010's | 1 (2.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonello, L | 1 |
| De Labriolle, A | 1 |
| Roy, P | 1 |
| Steinberg, DH | 1 |
| Okabe, T | 1 |
| Pinto Slottow, TL | 1 |
| Xue, Z | 1 |
| Torguson, R | 1 |
| Suddath, WO | 2 |
| Satler, LF | 2 |
| Kent, KM | 2 |
| Pichard, AD | 2 |
| Lindsay, J | 2 |
| Waksman, R | 2 |
| Mao, Y | 1 |
| Yu, JM | 1 |
| Zhang, F | 1 |
| Zhan, YQ | 1 |
| Hu, DY | 1 |
| Jiang, QW | 1 |
| Gruberg, L | 1 |
| Weissman, NJ | 1 |
| Pinnow, EE | 1 |
| Gevorkian, N | 1 |
| SCEBAT, L | 1 |
| RENAIS, J | 1 |
| LENEGRE, J | 1 |
| LOCKWOOD, CH | 1 |
| NICHOLLS, DM | 1 |
| LEWIS, JA | 1 |
| TROOP, VL | 1 |
| JOHNSTON, LC | 1 |
| GRIEBLE, HG | 1 |
| SCHOENBERGER, JA | 1 |
| FULLER, JB | 1 |
| IMAI, S | 1 |
| RILEY, AL | 1 |
| BERNE, RM | 1 |
| Weisbord, SD | 1 |
| Chen, H | 1 |
| Stone, RA | 1 |
| Kip, KE | 1 |
| Fine, MJ | 1 |
| Saul, MI | 1 |
| Palevsky, PM | 1 |
| Schaeverbeke, T | 1 |
| Héloire, F | 1 |
| Deray, G | 1 |
| Bersohn, MM | 1 |
| Shine, KI | 3 |
| Behrendt, W | 1 |
| Minale, C | 1 |
| Giani, G | 1 |
| Douglas, AM | 2 |
| Davydov, VV | 1 |
| Tverdokhlib, VP | 1 |
| Iakushev, VS | 1 |
| Roberts, JJ | 1 |
| Walker, JB | 1 |
| Hirano, T | 1 |
| Naito, H | 1 |
| Kurokawa, M | 1 |
| Ebara, T | 1 |
| Nagano, S | 1 |
| Adachi, M | 1 |
| Yoshino, G | 1 |
| Lip, GY | 1 |
| Rathore, VS | 1 |
| Katira, R | 1 |
| Singh, SP | 1 |
| Watson, RD | 1 |
| Kohn, MC | 1 |
| Achs, MJ | 1 |
| Garfinkel, D | 1 |
| Barlattani, M | 1 |
| Guglielmi, G | 2 |
| Mammarella, A | 2 |
| Di Maio, F | 1 |
| Neri, A | 1 |
| Soccorsi, P | 1 |
| Sciacca, A | 1 |
| Rau, EE | 1 |
| Gervais, A | 1 |
| Amos, EC | 1 |
| Cucchini, F | 1 |
| Colla, B | 1 |
| Di Donato, M | 1 |
| Visioli, O | 1 |
| Godfraind, T | 1 |
| Reibel, DK | 1 |
| Rovetto, MJ | 1 |
| Sigurd, B | 1 |
| Olesen, KH | 1 |
| Wennevold, A | 1 |
| Isselhard, W | 2 |
| Lauterjung, KL | 2 |
| Witte, J | 2 |
| Ban, T | 1 |
| Hübner, G | 1 |
| Giersberg, O | 1 |
| Heugel, E | 2 |
| Hirt, HJ | 1 |
| Geppert, E | 1 |
| Menge, M | 1 |
| Vogel, W | 1 |
| Pisarenko, OI | 2 |
| Studneva, IM | 2 |
| Shul'zhenko, VS | 1 |
| Khlopkov, VN | 1 |
| Novikov, ID | 1 |
| Kapel'ko, VI | 1 |
| Zucchi, R | 2 |
| Limbruno, U | 2 |
| Di Vincenzo, A | 1 |
| Mariani, M | 2 |
| Ronca, G | 2 |
| Otsu, N | 1 |
| Yamaguchi, I | 1 |
| Komatsu, E | 1 |
| Miyazawa, K | 1 |
| Oleynikov, OD | 1 |
| Shulzhenko, VS | 1 |
| Ryff, IM | 1 |
| Kapelko, VI | 1 |
| Poddighe, R | 1 |
| Ronca-Testoni, S | 1 |
| Zimmer, SD | 1 |
| Uğurbil, K | 1 |
| Michurski, SP | 1 |
| Mohanakrishnan, P | 1 |
| Ulstad, VK | 1 |
| Foker, JE | 1 |
| From, AH | 1 |
| Ingwall, JS | 1 |
| Kramer, MF | 1 |
| Fifer, MA | 1 |
| Lorell, BH | 1 |
| Shemin, R | 1 |
| Grossman, W | 1 |
| Allen, PD | 1 |
| Evanochko, WT | 1 |
| Reeves, RC | 1 |
| Sakai, TT | 1 |
| Canby, RC | 1 |
| Pohost, GM | 1 |
| Fiolet, JW | 1 |
| Baartscheer, A | 1 |
| Schumacher, CA | 1 |
| ter Welle, HF | 1 |
| Krieger, WJ | 1 |
| Sami, HM | 1 |
| Koke, JR | 1 |
| Bittar, N | 1 |
| Seppet, EK | 1 |
| Adoyaan, AJ | 1 |
| Kallikorm, AP | 1 |
| Chernousova, GB | 1 |
| Lyulina, NV | 1 |
| Sharov, VG | 1 |
| Severin, VV | 1 |
| Popovich, MI | 1 |
| Saks, VA | 1 |
| Fontana, A | 1 |
| Lusena, S | 1 |
| Mori, K | 1 |
| Fox, AC | 1 |
| Reed, GE | 1 |
| Glassman, E | 1 |
| Kaltman, AJ | 1 |
| Silk, BB | 1 |
| Telfer, N | 1 |
| Persoff, M | 1 |
| Chernukh, AM | 1 |
| Vakar, MD | 1 |
| Aleksandrov, PN | 1 |
| Chernysheva, GV | 1 |
| Stoĭda, LV | 1 |
| Natale, L | 1 |
| Moser, K | 2 |
| Lujf, A | 2 |
| Suko, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pragmatic Randomized Controlled Trial Comparing Treatment Effectiveness of Guideline Indicated Anti-platelet Therapy for Acute Coronary Syndrome in Patients With Chronic Kidney Disease[NCT03150667] | Phase 4 | 220 participants (Anticipated) | Interventional | 2017-04-10 | Recruiting | ||
| Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention[NCT03266458] | 210 participants (Anticipated) | Observational [Patient Registry] | 2018-01-01 | Not yet recruiting | |||
| Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II[NCT02592824] | Phase 3 | 321 participants (Actual) | Interventional | 2015-11-15 | Completed | ||
| Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery Disease[NCT00489827] | Phase 3 | 865 participants (Actual) | Interventional | 2005-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Postoperative mortality was defined as mortality within 30 days of surgery. (NCT02592824)
Timeframe: up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 1 |
| Intravenous Saline Infusion | 6 |
suspected unexpected serious adverse reaction (NCT02592824)
Timeframe: within 24 hours from infusion
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 0 |
| Intravenous Saline Infusion | 0 |
"Postoperative stroke was defined as neurological or cognitive deficit with a cerebral injury verified on (Computed Tomography) CT-scan. All suspected cases of stroke underwent CT-scan.~Stroke within 24 h of surgery was defined as a stroke that occurred within 24 h of surgery or signs of a stroke, when first assessable in deeply sedated patients on a ventilator." (NCT02592824)
Timeframe: within 24 hours from surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 0 |
| Intravenous Saline Infusion | 4 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~In the first GLUTAMICS trial a good agreement between hemodynamic criteria for postoperative heart failure and postoperative NT-proBNP was found." (NCT02592824)
Timeframe: from the day before surgery to the third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 5390 |
| Intravenous Saline Infusion | 6452 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~Previous observations suggest a blunted effect of glutamate in diabetic hearts." (NCT02592824)
Timeframe: from preoperative level to the third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 4503 |
| Intravenous Saline Infusion | 6825 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: first postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 4438 |
| Intravenous Saline Infusion | 4420 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 8055 |
| Intravenous Saline Infusion | 8804 |
Number of patients with atrial fibrillation recorded postoperatively (NCT00489827)
Timeframe: Hospital stay
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate | 147 |
| Saline Infusion | 152 |
ICU duration of stay (hours) (NCT00489827)
Timeframe: ICU stay
| Intervention | hours (Median) |
|---|---|
| Intravenous Glutamate | 21 |
| Saline Infusion | 21 |
(NCT00489827)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate | 31 |
| Saline Infusion | 25 |
Incidence of Postoperative stroke < 24 hours of surgery verifed by CT-scan (NCT00489827)
Timeframe: 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate | 4 |
| Saline Infusion | 6 |
Hemodynamic instability despite inotropes or need for IABP at the end of surgery in patients with severely reduced left ventricular ejection fraction (LVEF<0.40) (NCT00489827)
Timeframe: End of surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate | 1 |
| Saline Infusion | 5 |
maximum p-creatinine value recorded postoperatively < 30 days (NCT00489827)
Timeframe: 30 days
| Intervention | µmol/L (Mean) |
|---|---|
| Intravenous Glutamate | 106 |
| Saline Infusion | 106 |
Severe circulatory failure according to prespecified criteria as judged by a blinded endpoints committee in CCS class IV patients (NCT00489827)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate | 3 |
| Saline Infusion | 16 |
p-CK-MB postoperative day 1, p-troponin-T postoperative day 3 (NCT00489827)
Timeframe: perioperative
| Intervention | µg/L (Median) | |
|---|---|---|
| CK-MB day 1 | Troponin-T day 3 | |
| Intravenous Glutamate | 14 | 0.27 |
| Saline Infusion | 14 | 0.24 |
Mixed venous oxygen saturation (SvO2) measured at weaning from cardiopulmonary bypass and on arrival to ICU (NCT00489827)
Timeframe: Until arrival to ICU
| Intervention | percentage of saturated hemoglobin (Mean) | |
|---|---|---|
| SvO2 at weaning from CPB | SvO2 on arrival to ICU | |
| Intravenous Glutamate | 72.0 | 65.0 |
| Saline Infusion | 72.2 | 64.9 |
5 trials available for creatine and Coronary Disease
| Article | Year |
|---|---|
[Parenteral feeding following heart surgery operations].
Topics: Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Coronary Artery Bypass; Coronary Disease; Creati | 1984 |
Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Creatine; Double-Blind Meth | 1979 |
Activity of creatinol O-phosphate on persistent ventricular premature beats in ischemic heart disease. Double blind clinical trial.
Topics: Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Creatine; Double-Blind Metho | 1979 |
[Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Crea | 1979 |
The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
Topics: Adult; Bendroflumethiazide; Benzoates; Butylamines; Chlorides; Clinical Trials as Topic; Coronary Di | 1975 |
41 other studies available for creatine and Coronary Disease
| Article | Year |
|---|---|
Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome.
Topics: Acute Disease; Aged; Confidence Intervals; Coronary Angiography; Coronary Disease; Creatine; Disease | 2008 |
[The association of target organ damage with abnormal ankle brachial index in hypertensive patients].
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Arteriosclerosis; China; Coronary Disease; Cre | 2012 |
Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention.
Topics: Age Factors; Aged; Comorbidity; Coronary Artery Bypass; Coronary Disease; Creatine; Diabetes Mellitu | 2003 |
[Serum creatine-kinase in the diagnosis of myocardial lesions. (Clinical and experimental study)].
Topics: Clinical Enzyme Tests; Coronary Disease; Creatine; Creatinine; Humans; Phosphotransferases | 1961 |
THE DIURETIC EFFECT OF TRIAMTERENE.
Topics: Blood Chemical Analysis; Coronary Disease; Creatine; Creatinine; Diuretics; Heart Failure; Hypertens | 1964 |
TREATMENT OF ARTERIAL HYPERTENSIVE DISEASE WITH DIURETICS. III. CHLORTHALIDONE ALONE AND IN COMBINATION WITH SPIRONOLACTONE.
Topics: Bendroflumethiazide; Cardiomegaly; Chlorides; Chlorthalidone; Coronary Disease; Creatine; Creatinine | 1964 |
EFFECT OF ISCHEMIA ON ADENINE NUCLEOTIDES IN CARDIAC AND SKELETAL MUSCLE.
Topics: Adenine Nucleotides; Coenzymes; Coronary Disease; Creatine; Creatinine; Heart; Metabolism; Muscle, S | 1964 |
Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography.
Topics: Aged; Coronary Disease; Creatine; Female; Hospital Mortality; Humans; Kidney; Length of Stay; Male; | 2006 |
[How to watch over a patient treated with a NSAID in relation to the cardiovascular and renal risk?].
Topics: Adult; Age Factors; Aged; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseas | 2006 |
Verapamil protection of ischemic isolated rabbit heart: dependence on pretreatment.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Calcium; Coronary Disease; Creatine; In Vitro Techn | 1983 |
Low calcium reperfusion of ischemic myocardium.
Topics: Adenosine Triphosphate; Animals; Calcium; Coronary Disease; Creatine; Electric Stimulation; Myocardi | 1983 |
[Concentration of adenylic nucleotides and creatine phosphate in the cerebral hemispheres in various manifestations of stress].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Brain Chemistry; Coronary Disease; Creatine; N | 1982 |
Feeding a creatine analogue delays ATP depletion and onset of rigor in ischemic heart.
Topics: Adenosine Triphosphate; Animals; Coronary Disease; Creatine; Creatinine; Heart; Kinetics; Male; Myoc | 1982 |
High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
Topics: Aged; Albuminuria; Apoproteins; Blood Glucose; Body Mass Index; Carrier Proteins; Cholesterol Ester | 1996 |
Changes in renal function with percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Coronary Disease; Creatine; Female; Follow-Up Studies; H | 1999 |
Distribution of adenine nucleotides in the perfused rat heart.
Topics: Actins; Adenine Nucleotides; Animals; Computers; Coronary Disease; Creatine; Cytosol; Glucose; Hydro | 1977 |
Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion.
Topics: Amino Acids; Animals; Arginine; Aspartic Acid; Coronary Disease; Creatine; Glutamates; Hypoxia; Male | 1979 |
Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion.
Topics: Amino Acids; Animals; Arginine; Aspartic Acid; Coronary Disease; Creatine; Glutamates; Hypoxia; Male | 1979 |
Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion.
Topics: Amino Acids; Animals; Arginine; Aspartic Acid; Coronary Disease; Creatine; Glutamates; Hypoxia; Male | 1979 |
Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion.
Topics: Amino Acids; Animals; Arginine; Aspartic Acid; Coronary Disease; Creatine; Glutamates; Hypoxia; Male | 1979 |
[Effects of creatinol-O-phosphate on left ventricular function in coronary disease patients].
Topics: Coronary Disease; Creatine; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction | 1978 |
Concepts leading to the development of an anti-ischemic drug. Introductory remarks.
Topics: Coronary Disease; Creatine; Hemodynamics; Humans; Myocardial Contraction; Necrosis | 1979 |
Myocardial ATP synthesis and mechanical function following oxygen deficiency.
Topics: Adenosine; Adenosine Triphosphate; Animals; Coronary Disease; Creatine; In Vitro Techniques; Male; M | 1978 |
Metabolic and structural recovery of left ventricular canine myocardium from regional complete ischemia.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cell Nucleus; Colla | 1975 |
Effect on myocardial metabolic pattern of local complete and incomplete ischemia.
Topics: Adenosine Monophosphate; Animals; Coronary Disease; Creatine; Disease Models, Animal; Dogs; Glycogen | 1975 |
[Relation between the energy state of the myocardium and the release of products of anaerobic metabolism].
Topics: Adenosine Triphosphate; Alanine; Anaerobiosis; Animals; Bicarbonates; Buffers; Coronary Disease; Cre | 1990 |
Adenine nucleotide depletion and contractile dysfunction in the "stunned" myocardium.
Topics: Adenine Nucleotides; Animals; Coronary Disease; Creatine; In Vitro Techniques; Myocardial Contractio | 1990 |
[Immunoelectron microscopic studies on the localization of creatine kinase M in normal and ischemic myocardial cells].
Topics: Adenosine Triphosphate; Animals; Coronary Disease; Creatine; Creatine Kinase; Dogs; Energy Metabolis | 1990 |
Association of myocardial glutamate and aspartate pool and functional recovery of postischemic heart.
Topics: Adenosine Triphosphate; Animals; Aspartic Acid; Coronary Disease; Creatine; Energy Metabolism; Gluta | 1989 |
Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate.
Topics: Animals; Coronary Disease; Creatine; Heart; Hemodynamics; Hydrogen Peroxide; Hypoxia; In Vitro Techn | 1989 |
Alterations in oxidative function and respiratory regulation in the post-ischemic myocardium.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Coronary Disease; Creatine; Energy Metabolism; | 1989 |
The creatine kinase system in normal and diseased human myocardium.
Topics: Adult; Aged; Aortic Valve Stenosis; Cardiomegaly; Citrate (si)-Synthase; Coronary Disease; Creatine; | 1985 |
Proton NMR spectroscopy in myocardial ischemic insult.
Topics: Animals; Coronary Circulation; Coronary Disease; Creatine; Dogs; Fatty Acids, Nonesterified; Lipid M | 1987 |
Transmural inhomogeneity of energy metabolism during acute global ischemia in the isolated rat heart: dependence on environmental conditions.
Topics: Adenosine Triphosphate; Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Cre | 1985 |
Accelerated recovery of ischemic canine myocardium induced by AMP. Preliminary report.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Coronary Disease; C | 1985 |
Hormone regulation of cardiac energy metabolism. I. Creatine transport across cell membranes of euthyroid and hyperthyroid rat heart.
Topics: Animals; Cell Membrane; Coronary Disease; Creatine; Energy Metabolism; Hyperthyroidism; Kinetics; My | 1985 |
[Clinical study on the effects of creatinol-O-phosphate in patients with heart diseases under digitalis treatment].
Topics: Aged; Alcohols; Arrhythmias, Cardiac; Coronary Disease; Creatine; Drug Synergism; Drug Tolerance; Fe | 1972 |
[Effect of exercise on myocardial metabolism of inorganic phosphorus and creatine in patients with heart diseases].
Topics: Adult; Asthenia; Coronary Disease; Coronary Vessels; Creatine; Female; Heart Diseases; Heart Valve D | 1972 |
Release of adenosine from human hearts during angina induced by rapid atrial pacing.
Topics: Adenosine; Adult; Aged; Angina Pectoris; Animals; Arteriosclerosis; Coronary Disease; Creatine; Crea | 1974 |
The effect of tube feeding on the hydration of elderly patients.
Topics: Aged; Anuria; Blood Urea Nitrogen; Cerebrovascular Disorders; Chemistry Techniques, Analytical; Coro | 1965 |
[Functional changes in the heart in experimental microcirculatory disorders].
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals | 1971 |
[Treatment of patients with coronary insufficiency with creatinol-o-phosphate].
Topics: Coronary Disease; Creatine; Female; Humans; Male; Phosphates | 1968 |
[Enzyme activities, energy phosphates and noradrenaline content in the isolated ischemic guinea pig myocardium].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Coronary Disease; Creatine; Enzymes; Guinea Pi | 1968 |
[Effect of oxyfedrine on the enzymatic activity and on energy rich phosphates of isolated ischemic guinea pig heart].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Coronary Disease; Creatine; Depression, Chemic | 1969 |